// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Brain phenotype of takotsubo syndrome

Hilal Khan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

White matter hyperintensities

N/A

Improving the diagnostic accuracy of apical hypertrophic cardiomyopathy

Rebecca Hughes - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Silent cerebral microinfarction following mitral valve surgery

Miroslawa Gorecka - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Investigating a novel role for nesprin 1 and the linc complex in cardiomyocyte mechanotransduction

Shanelle de Silva - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prezatide copper acetate

The utility of exercise stress echocardiography for pre pregnancy risk stratification in patients with left heart obstruction

Sean Malone - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Transcatheter aortic valve implantation in patients with right bundle branch block should prophylactic pacing be undertaken

Chris Pavitt - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Disease penetrance in asymptomatic carriers of familial cardiomyopathy variants

Adil Mahmood - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Is pulmonary artery dilatation part of the athletic adaptation to exercise

Nikhil Chatrath - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Sudden cardiac death during exercise in young individuals with hypertrophic cardiomyopathy

Raghav Bhatia - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

The long term effects of adipose depot change following bariatric surgery on cardiac geometry

John Aaron Henry - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Impact of epilepsy or seizures on outcomes following takotsubo cardiomyopathy

Raheel Ahmed - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Takotsubo cardiomyopathy

N/A

Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation a systematic review and meta analysis

Qi Zhuang Siah - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Hypertrophic cardiomyopathy

N/A

The effects of social deprivation on clinical outcomes in infective endocarditis

Samuel Watson - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infective endocarditis

N/A

Analysis of a hypertrophic cardiomyopathy cohort in a regional inherited cardiac conditions service with a focus on eligibility for novel cardiac myosin inhibitor therapies

Leo Mansell - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

A review of the adult fontan population in yorkshire and the humber

lydia bevis - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Atherosclerosis in fabry disease

Ashwin Roy - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Reducing burden of ambulatory care in adult congenital heart disease to improve health outcomes a cohort study

Louise Coats - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

An evaluation into the compliance of iron tablets in adults with congenital hearts disease and iron deficiency anaemia

Priya Agarwal - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Anemia

N/A

Management of acute pericarditis and myocarditis are our patients missing out on esc guideline based practice

Matt Church - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pericarditis

N/A

Cerebral abscess in adult congenital heart disease achd a single centre experience

Eleanor Joy - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Copyright © 2026. QuantiNova All rights reserved